Katie Crouch dice que llamar a la agencia de Medicaid de su estado para obtener información sobre sus beneficios parece un callejón sin salida. “La primera vez, el teléfono suena sin parar. La siguiente, te manda al buzón de voz y se corta la llamada”, dijo la mujer de 48 años, que vive en Delaware….
The privatization of Medicare has been taking place without much public debate – a trend that has implications for the 68 million people covered by Medicare, health care providers, Medicare spending, and taxpayers. It’s not yet clear whether the administration will promote policies to accelerate the privatization of Medicare or focus more on achieving efficiencies…
When it comes to the effects that the upcoming Trump presidency will have on healthcare, attendees’ attitudes ranged from cautiously optimistic to fairly anxious. Some of the issues they highlighted included mental health parity, telehealth prescribing flexibilities, and the role of Robert F. Kennedy Jr. The post How Did Attendees at a Behavioral Health Conference…
The FDA approved Sanofi and Regeneron Pharmaceuticals drug Dupixent as a treatment for the inflammatory skin disorder chronic spontaneous urticaria. The regulatory decision comes two years after the agency turned down an application for the biologic drug in this indication. The post Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin…
Workplace violence prevention is an ongoing and organic process. Federal and state regulations change frequently, so employers may consider regularly reviewing and updating their prevention plans and training programs on a scheduled timeline. The post Workplace Violence Prevention in 2025 appeared first on MedCity News.
Noom recently launched a microdosing program for GLP-1s. However, some are concerned about the use of compounded GLP-1s in this program, as they are not FDA-approved. The post GLP-1s Come With High Price Tags and Major Side Effects. Could Microdosing Be the Answer? appeared first on MedCity News.
Anna Taylor, the MultiCare ACO’s associate vice president of population health and value-based care, and Tuva Health CEO Aaron Neiderhiser discuss their partnership
At Epic’s annual Users Group Meeting, the EHR behemoth highlighted its growing AI strategy — announcing tools promising to benefit providers, payers and patients alike. The post 3 Announcements You Don’t Want to Miss from Epic’s Annual Meeting appeared first on MedCity News.
A new PwC report says the women’s oncology market could reach $110 billion by 2030, though funding and care gaps remain. The post Women’s Oncology Market Could Reach $110B in 2030, but Gaps Remain appeared first on MedCity News.
By STEVEN ZECOLA Artificial intelligence (“AI”) has taken root in the field of drug discovery and development and already has shown signs of running past the traditional model of doing research. Congress should take note of these rapid changes and: 1) direct the Department of Health and Human Services (“HHS”) to phase down the government’s…